Table 3 Predicted Cw*0401-specific immunological hotspots for gp160gag.
From: In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
No. | Position | Sequence |
|---|---|---|
1 | 44–89 | VWKEATTTLFCASDAKAYDTEVHNVWATHACVPTDPNPQEVVLVNV |
2 | 102–171 | EQMHEDIISLWDQSLKPCVKLTPLCVSLKCTDLGNATNTNSSNTNSSSGEMM MEKGEIKNCSFNISTSIR |
3 | 174–289 | VQKEYAFFYKLDIIPIDNDTTSYTLTSCNTSVITQACPKVSFEPIPIHYCAP AGFAILKCNNKTFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEVVI RSANFTDNAKTI |
4 | 341–504 | AKWNATLKQIASKLREQFGNNKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNS TQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRIKQFINMWQEVGKAMYAPPI SGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDMRDNWRSELYKYKVVKI EPLGVAPT |
5 | 489–559 | KYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGARSMT LTVQARQLLSGIVQQQNN |
6 | 581–639 | LQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNNMT WMEWDRE |
7 | 667–721 | ELDKWASLWNWFNITNWLWYIKIFIMIVGGLVGLRIVFAVLSIVNRVRQGYS PLS |
8 | 708–766 | SIVNRVRQGYSPLSFQTHLPTPRGPDRPEGIEEEGGERDRDRSIRLVNGSLA LIWDDLR |
9 | 793–852 | RGWEALKYWWNLLQYWSQELKNSAVSLLNATAIAVAEGTDRVIEVVQGACRA IRHIPRRI |